Your shopping cart is currently empty

NBD-2 is an inhibitor targeting the NEMO-IKKα/β interaction within the NF-κB signaling pathway. It can specifically suppress the canonical NF-κB signaling both in vitro and in vivo, thereby reducing the inflammatory response in acute lung injury (ALI) induced by lipopolysaccharide (LPS). NBD-2 demonstrates significant anti-inflammatory activity and is applicable for research on diseases related to the NF-κB signaling pathway, such as autoimmune disorders and cancer.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | NBD-2 is an inhibitor targeting the NEMO-IKKα/β interaction within the NF-κB signaling pathway. It can specifically suppress the canonical NF-κB signaling both in vitro and in vivo, thereby reducing the inflammatory response in acute lung injury (ALI) induced by lipopolysaccharide (LPS). NBD-2 demonstrates significant anti-inflammatory activity and is applicable for research on diseases related to the NF-κB signaling pathway, such as autoimmune disorders and cancer. |
| Formula | C73H86F8N14O17S2 |
| Sequence | Thr-Ala-Leu-Cys-Trp-Cys-Trp-Leu-Gln-Thr-Glu (Cyclo(Cys4-2(4F-Ph)-Cys6) |
| Sequence Short | TALCWCWLQTE (Cyclo(Cys4-2(4F-Ph)-Cys6) |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.